Researchers seek to end disparities in cancer, stroke care

NewsGuard 100/100 Score
HealthDay/U.S. News & World Report: Research has shown that there is a racial gap in breast cancer care, "with black and Hispanic women less likely to get recommended breast cancer treatments than white patients." A new study by researchers at the Dana Farber Cancer Institute "suggests that financial factors such as economic and social class or access to insurance alone can't explain the 'gap': Even after accounting for those differences, racial disparities in breast cancer care still showed up" (Doheny, 10/12).

The Associated Press/The Washington Post:  "Too few stroke sufferers get ... clot-busting treatment, especially black and Hispanic patients who are at highest risk of having a stroke and also may be particularly hesitant to seek fast care. New research is targeting those underserved populations to better spread the word that 'time is brain' — the faster you move the more brain you save" (Neergaard, 10/12).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
FDA-approved TIVDAK®: Targeting tissue factor in cervical cancer